These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 32063180)

  • 21. Combination of crystalloid (glucose) and colloid (icodextrin) osmotic agents markedly enhances peritoneal fluid and solute transport during the long PD dwell.
    Freida P; Galach M; Divino Filho JC; Werynski A; Lindholm B
    Perit Dial Int; 2007; 27(3):267-76. PubMed ID: 17468474
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Two icodextrin exchanges per day in peritoneal dialysis patients with ultrafiltration failure: one center's experience and review of the literature.
    Dousdampanis P; Trigka K; Chu M; Khan S; Venturoli D; Oreopoulos DG; Bargman JM
    Int Urol Nephrol; 2011 Mar; 43(1):203-9. PubMed ID: 20953705
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An update on peritoneal dialysis solutions.
    García-López E; Lindholm B; Davies S
    Nat Rev Nephrol; 2012 Feb; 8(4):224-33. PubMed ID: 22349485
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dialysis with icodextrin interferes with measurement of serum alpha-amylase activity.
    Schoenicke G; Grabensee B; Plum J
    Nephrol Dial Transplant; 2002 Nov; 17(11):1988-92. PubMed ID: 12401858
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sodium removal and peritoneal dialysis modalities: no differences with optimal prescription of icodextrin.
    Fourtounas C; Dousdampanis P; Hardalias A; Vlachojannis JG
    Artif Organs; 2013 Jul; 37(7):E107-13. PubMed ID: 23461737
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Icodextrin provides long dwell peritoneal dialysis and maintenance of intraperitoneal volume.
    Peers E; Gokal R
    Artif Organs; 1998 Jan; 22(1):8-12. PubMed ID: 9456219
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Automated peritoneal dialysis prescriptions for enhancing sodium and fluid removal: a predictive analysis of optimized, patient-specific dwell times for the day period.
    Akonur A; Guest S; Sloand JA; Leypoldt JK
    Perit Dial Int; 2013; 33(6):646-54. PubMed ID: 24335125
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predicting the Peritoneal Absorption of Icodextrin in Rats and Humans Including the Effect of α-Amylase Activity in Dialysate.
    Akonur A; Holmes CJ; Leypoldt JK
    Perit Dial Int; 2015; 35(3):288-96. PubMed ID: 24584610
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Icodextrin: What arguments for and against its use as an osmotic agent in peritoneal dialysis].
    Savenkoff B; Flechon-Meibody F; Goffin É
    Nephrol Ther; 2018 Jun; 14(4):201-206. PubMed ID: 29291942
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Peritonitis occurrence in a multicenter study of icodextrin and glucose in CAPD. MIDAS Study Group. Multicenter Investigation of Icodextrin in Ambulatory Dialysis.
    Gokal R; Mistry CD; Peers EM
    Perit Dial Int; 1995; 15(6):226-30. PubMed ID: 7578498
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Indirect ion selective electrode methods potentially overestimate peritoneal dialysate sodium losses.
    Persaud J; Thomas M; Davenport A
    Ther Apher Dial; 2014 Aug; 18(4):321-5. PubMed ID: 24206257
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biocompatible dialysis fluids for peritoneal dialysis.
    Cho Y; Johnson DW; Craig JC; Strippoli GF; Badve SV; Wiggins KJ
    Cochrane Database Syst Rev; 2014 Mar; (3):CD007554. PubMed ID: 24671928
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Use of icodextrin for diurnal exchange in patients undergoing automatic peritoneal dialysis. Comparison with glucose solutions].
    Bajo MA; Selgas R; del Peso G; Castro MJ; Hevia C; Gil F; Costero O; Olea T; Jiménez C
    Nefrologia; 2002; 22(4):348-55. PubMed ID: 12369126
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and safety of a 7.5% icodextrin peritoneal dialysis solution in patients treated with automated peritoneal dialysis.
    Plum J; Gentile S; Verger C; Brunkhorst R; Bahner U; Faller B; Peeters J; Freida P; Struijk DG; Krediet RT; Grabensee B; Tranaeus A; Filho JC
    Am J Kidney Dis; 2002 Apr; 39(4):862-71. PubMed ID: 11920355
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of icodextrin in peritoneal dialysis: protocol for a systematic review and meta-analysis.
    Becker M; Bühn S; Breuing J; Firanek CA; Hess S; Nariai H; Marshall MR; Sloand JA; Yao Q; Goossen K; Pieper D
    Syst Rev; 2019 Jan; 8(1):35. PubMed ID: 30700329
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Kinetic analysis of peritoneal fluid and solute transport with combination of glucose and icodextrin as osmotic agents.
    Galach M; Werynski A; Waniewski J; Freida P; Lindholm B
    Perit Dial Int; 2009; 29(1):72-80. PubMed ID: 19164256
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of peritonitis on peritoneal transport characteristics: glucose solution versus polyglucose solution.
    Wang T; Cheng HH; Heimbürger O; Waniewski J; Bergström J; Lindholm B
    Kidney Int; 2000 Apr; 57(4):1704-12. PubMed ID: 10760106
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glucose absorption from peritoneal dialysate is associated with a gain in fat mass and a reduction in lean body mass in prevalent peritoneal dialysis patients.
    Law S; Davenport A
    Br J Nutr; 2020 Jun; 123(11):1269-1276. PubMed ID: 31992383
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictors of a favourable response to icodextrin in peritoneal dialysis patients with ultrafiltration failure.
    Wiggins KJ; Rumpsfeld M; Blizzard S; Johnson DW
    Nephrology (Carlton); 2005 Feb; 10(1):33-6. PubMed ID: 15705179
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Icodextrin use for peritoneal dialysis in Australia: A cohort study using Australia and New Zealand Dialysis and Transplant Registry.
    Rangaswamy D; Guddattu V; Webster AC; Borlace M; Boudville N; Clayton P; Badve S; Johnson DW; Sud K
    Perit Dial Int; 2020 Mar; 40(2):209-219. PubMed ID: 32063201
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.